EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biotechnological Advances in Genetic Disease Screening

Austra Lian, Screening Michael Taylor, Emma Richards

American Journal of Biotechnology · 31.12.2025 · 6 (6) · 1-5

DOI: 10.71465/ajbt3490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Biotechnology, online erschienen am 31.12.2025. Verfasst von Austra Lian und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic diseases are a significant global health concern, with millions of individuals affected by inherited disorders. Advances in biotechnology have revolutionized the field of genetic disease screening, enabling early detection, accurate diagnosis, and personalized treatment options. Technologies such as next-generation sequencing (NGS), CRISPR-based tools, and gene editing have opened new avenues for screening genetic disorders, allowing for precise identification of mutations and variants. This article discusses recent biotechnological advances in genetic disease screening, focusing on their impact on healthcare, challenges in implementation, and future directions.

Zitieren

APA

Lian, A., Taylor, S. M., & Richards, E. (2025). Biotechnological Advances in Genetic Disease Screening. American Journal of Biotechnology, 6(6), 1-5. https://doi.org/10.71465/ajbt3490

Vancouver

Lian A, Taylor SM, Richards E. Biotechnological Advances in Genetic Disease Screening. American Journal of Biotechnology. 2025;6(6):1-5. doi:10.71465/ajbt3490

BibTeX
@article{Lian2025,
  author = {Lian, Austra and Taylor, Screening Michael and Richards, Emma},
  title = {Biotechnological Advances in Genetic Disease Screening},
  journal = {American Journal of Biotechnology},
  year = {2025},
  volume = {6},
  number = {6},
  pages = {1--5},
  doi = {10.71465/ajbt3490}
}
Kostenlos starten →